Global Long-Acting Injectables Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Publisher Name :
Date: 10-Nov-2020
No. of pages: 125

The Long-Acting Injectables market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Long-Acting Injectables market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Long-Acting Injectables market. The report focuses on well-known providers in the global Long-Acting Injectables industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Long-Acting Injectables Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Long-Acting Injectables market covered in Chapter 4:

Pfizer

Lupin Limited

Eli Lilly

Medincel

Zogenix

Johnson & Johnson

DURECT

GlaxoSmithKline

In Chapter 11 and 13.3, on the basis of types, the Long-Acting Injectables market from 2015 to 2026 is primarily split into:

Small and Middle Sized Molecule

Large Sized Molecule

In Chapter 12 and 13.4, on the basis of applications, the Long-Acting Injectables market from 2015 to 2026 covers:

Schizophrenia

Other Psychotic Disorders

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

Global Long-Acting Injectables Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Long-Acting Injectables Market Share by Type (2020-2026)
1.5.2 Small and Middle Sized Molecule
1.5.3 Large Sized Molecule
1.6 Market by Application
1.6.1 Global Long-Acting Injectables Market Share by Application (2020-2026)
1.6.2 Schizophrenia
1.6.3 Other Psychotic Disorders
1.7 Long-Acting Injectables Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Long-Acting Injectables Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter's Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Long-Acting Injectables Market
3.1 Value Chain Status
3.2 Long-Acting Injectables Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Long-Acting Injectables
3.2.3 Labor Cost of Long-Acting Injectables
3.2.3.1 Labor Cost of Long-Acting Injectables Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Pfizer
4.1.1 Pfizer Basic Information
4.1.2 Long-Acting Injectables Product Profiles, Application and Specification
4.1.3 Pfizer Long-Acting Injectables Market Performance (2015-2020)
4.1.4 Pfizer Business Overview
4.2 Lupin Limited
4.2.1 Lupin Limited Basic Information
4.2.2 Long-Acting Injectables Product Profiles, Application and Specification
4.2.3 Lupin Limited Long-Acting Injectables Market Performance (2015-2020)
4.2.4 Lupin Limited Business Overview
4.3 Eli Lilly
4.3.1 Eli Lilly Basic Information
4.3.2 Long-Acting Injectables Product Profiles, Application and Specification
4.3.3 Eli Lilly Long-Acting Injectables Market Performance (2015-2020)
4.3.4 Eli Lilly Business Overview
4.4 Medincel
4.4.1 Medincel Basic Information
4.4.2 Long-Acting Injectables Product Profiles, Application and Specification
4.4.3 Medincel Long-Acting Injectables Market Performance (2015-2020)
4.4.4 Medincel Business Overview
4.5 Zogenix
4.5.1 Zogenix Basic Information
4.5.2 Long-Acting Injectables Product Profiles, Application and Specification
4.5.3 Zogenix Long-Acting Injectables Market Performance (2015-2020)
4.5.4 Zogenix Business Overview
4.6 Johnson & Johnson
4.6.1 Johnson & Johnson Basic Information
4.6.2 Long-Acting Injectables Product Profiles, Application and Specification
4.6.3 Johnson & Johnson Long-Acting Injectables Market Performance (2015-2020)
4.6.4 Johnson & Johnson Business Overview
4.7 DURECT
4.7.1 DURECT Basic Information
4.7.2 Long-Acting Injectables Product Profiles, Application and Specification
4.7.3 DURECT Long-Acting Injectables Market Performance (2015-2020)
4.7.4 DURECT Business Overview
4.8 GlaxoSmithKline
4.8.1 GlaxoSmithKline Basic Information
4.8.2 Long-Acting Injectables Product Profiles, Application and Specification
4.8.3 GlaxoSmithKline Long-Acting Injectables Market Performance (2015-2020)
4.8.4 GlaxoSmithKline Business Overview

5 Global Long-Acting Injectables Market Analysis by Regions
5.1 Global Long-Acting Injectables Sales, Revenue and Market Share by Regions
5.1.1 Global Long-Acting Injectables Sales by Regions (2015-2020)
5.1.2 Global Long-Acting Injectables Revenue by Regions (2015-2020)
5.2 North America Long-Acting Injectables Sales and Growth Rate (2015-2020)
5.3 Europe Long-Acting Injectables Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Long-Acting Injectables Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Long-Acting Injectables Sales and Growth Rate (2015-2020)
5.6 South America Long-Acting Injectables Sales and Growth Rate (2015-2020)

6 North America Long-Acting Injectables Market Analysis by Countries
6.1 North America Long-Acting Injectables Sales, Revenue and Market Share by Countries
6.1.1 North America Long-Acting Injectables Sales by Countries (2015-2020)
6.1.2 North America Long-Acting Injectables Revenue by Countries (2015-2020)
6.1.3 North America Long-Acting Injectables Market Under COVID-19
6.2 United States Long-Acting Injectables Sales and Growth Rate (2015-2020)
6.2.1 United States Long-Acting Injectables Market Under COVID-19
6.3 Canada Long-Acting Injectables Sales and Growth Rate (2015-2020)
6.4 Mexico Long-Acting Injectables Sales and Growth Rate (2015-2020)

7 Europe Long-Acting Injectables Market Analysis by Countries
7.1 Europe Long-Acting Injectables Sales, Revenue and Market Share by Countries
7.1.1 Europe Long-Acting Injectables Sales by Countries (2015-2020)
7.1.2 Europe Long-Acting Injectables Revenue by Countries (2015-2020)
7.1.3 Europe Long-Acting Injectables Market Under COVID-19
7.2 Germany Long-Acting Injectables Sales and Growth Rate (2015-2020)
7.2.1 Germany Long-Acting Injectables Market Under COVID-19
7.3 UK Long-Acting Injectables Sales and Growth Rate (2015-2020)
7.3.1 UK Long-Acting Injectables Market Under COVID-19
7.4 France Long-Acting Injectables Sales and Growth Rate (2015-2020)
7.4.1 France Long-Acting Injectables Market Under COVID-19
7.5 Italy Long-Acting Injectables Sales and Growth Rate (2015-2020)
7.5.1 Italy Long-Acting Injectables Market Under COVID-19
7.6 Spain Long-Acting Injectables Sales and Growth Rate (2015-2020)
7.6.1 Spain Long-Acting Injectables Market Under COVID-19
7.7 Russia Long-Acting Injectables Sales and Growth Rate (2015-2020)
7.7.1 Russia Long-Acting Injectables Market Under COVID-19

8 Asia-Pacific Long-Acting Injectables Market Analysis by Countries
8.1 Asia-Pacific Long-Acting Injectables Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Long-Acting Injectables Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Long-Acting Injectables Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Long-Acting Injectables Market Under COVID-19
8.2 China Long-Acting Injectables Sales and Growth Rate (2015-2020)
8.2.1 China Long-Acting Injectables Market Under COVID-19
8.3 Japan Long-Acting Injectables Sales and Growth Rate (2015-2020)
8.3.1 Japan Long-Acting Injectables Market Under COVID-19
8.4 South Korea Long-Acting Injectables Sales and Growth Rate (2015-2020)
8.4.1 South Korea Long-Acting Injectables Market Under COVID-19
8.5 Australia Long-Acting Injectables Sales and Growth Rate (2015-2020)
8.6 India Long-Acting Injectables Sales and Growth Rate (2015-2020)
8.6.1 India Long-Acting Injectables Market Under COVID-19
8.7 Southeast Asia Long-Acting Injectables Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Long-Acting Injectables Market Under COVID-19

9 Middle East and Africa Long-Acting Injectables Market Analysis by Countries
9.1 Middle East and Africa Long-Acting Injectables Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Long-Acting Injectables Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Long-Acting Injectables Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Long-Acting Injectables Market Under COVID-19
9.2 Saudi Arabia Long-Acting Injectables Sales and Growth Rate (2015-2020)
9.3 UAE Long-Acting Injectables Sales and Growth Rate (2015-2020)
9.4 Egypt Long-Acting Injectables Sales and Growth Rate (2015-2020)
9.5 Nigeria Long-Acting Injectables Sales and Growth Rate (2015-2020)
9.6 South Africa Long-Acting Injectables Sales and Growth Rate (2015-2020)

10 South America Long-Acting Injectables Market Analysis by Countries
10.1 South America Long-Acting Injectables Sales, Revenue and Market Share by Countries
10.1.1 South America Long-Acting Injectables Sales by Countries (2015-2020)
10.1.2 South America Long-Acting Injectables Revenue by Countries (2015-2020)
10.1.3 South America Long-Acting Injectables Market Under COVID-19
10.2 Brazil Long-Acting Injectables Sales and Growth Rate (2015-2020)
10.2.1 Brazil Long-Acting Injectables Market Under COVID-19
10.3 Argentina Long-Acting Injectables Sales and Growth Rate (2015-2020)
10.4 Columbia Long-Acting Injectables Sales and Growth Rate (2015-2020)
10.5 Chile Long-Acting Injectables Sales and Growth Rate (2015-2020)

11 Global Long-Acting Injectables Market Segment by Types
11.1 Global Long-Acting Injectables Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Long-Acting Injectables Sales and Market Share by Types (2015-2020)
11.1.2 Global Long-Acting Injectables Revenue and Market Share by Types (2015-2020)
11.2 Small and Middle Sized Molecule Sales and Price (2015-2020)
11.3 Large Sized Molecule Sales and Price (2015-2020)

12 Global Long-Acting Injectables Market Segment by Applications
12.1 Global Long-Acting Injectables Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Long-Acting Injectables Sales and Market Share by Applications (2015-2020)
12.1.2 Global Long-Acting Injectables Revenue and Market Share by Applications (2015-2020)
12.2 Schizophrenia Sales, Revenue and Growth Rate (2015-2020)
12.3 Other Psychotic Disorders Sales, Revenue and Growth Rate (2015-2020)

13 Long-Acting Injectables Market Forecast by Regions (2020-2026)
13.1 Global Long-Acting Injectables Sales, Revenue and Growth Rate (2020-2026)
13.2 Long-Acting Injectables Market Forecast by Regions (2020-2026)
13.2.1 North America Long-Acting Injectables Market Forecast (2020-2026)
13.2.2 Europe Long-Acting Injectables Market Forecast (2020-2026)
13.2.3 Asia-Pacific Long-Acting Injectables Market Forecast (2020-2026)
13.2.4 Middle East and Africa Long-Acting Injectables Market Forecast (2020-2026)
13.2.5 South America Long-Acting Injectables Market Forecast (2020-2026)
13.3 Long-Acting Injectables Market Forecast by Types (2020-2026)
13.4 Long-Acting Injectables Market Forecast by Applications (2020-2026)
13.5 Long-Acting Injectables Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source

List of Tables and Figures
Table Global Long-Acting Injectables Market Size Growth Rate by Type (2020-2026)
Figure Global Long-Acting Injectables Market Share by Type in 2019 & 2026
Figure Small and Middle Sized Molecule Features
Figure Large Sized Molecule Features
Table Global Long-Acting Injectables Market Size Growth by Application (2020-2026)
Figure Global Long-Acting Injectables Market Share by Application in 2019 & 2026
Figure Schizophrenia Description
Figure Other Psychotic Disorders Description
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Long-Acting Injectables Industry Development
Table SWOT Analysis
Figure Porter's Five Forces Analysis
Figure Global Long-Acting Injectables Market Size and Growth Rate 2015-2026
Table Industry News
Table Industry Policies
Figure Value Chain Status of Long-Acting Injectables
Figure Production Process of Long-Acting Injectables
Figure Manufacturing Cost Structure of Long-Acting Injectables
Figure Major Company Analysis (by Business Distribution Base, by Product Type)
Table Downstream Major Customer Analysis (by Region)
Table Pfizer Profile
Table Pfizer Production, Value, Price, Gross Margin 2015-2020
Table Lupin Limited Profile
Table Lupin Limited Production, Value, Price, Gross Margin 2015-2020
Table Eli Lilly Profile
Table Eli Lilly Production, Value, Price, Gross Margin 2015-2020
Table Medincel Profile
Table Medincel Production, Value, Price, Gross Margin 2015-2020
Table Zogenix Profile
Table Zogenix Production, Value, Price, Gross Margin 2015-2020
Table Johnson & Johnson Profile
Table Johnson & Johnson Production, Value, Price, Gross Margin 2015-2020
Table DURECT Profile
Table DURECT Production, Value, Price, Gross Margin 2015-2020
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2015-2020
Figure Global Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Global Long-Acting Injectables Revenue ($) and Growth (2015-2020)
Table Global Long-Acting Injectables Sales by Regions (2015-2020)
Table Global Long-Acting Injectables Sales Market Share by Regions (2015-2020)
Table Global Long-Acting Injectables Revenue ($) by Regions (2015-2020)
Table Global Long-Acting Injectables Revenue Market Share by Regions (2015-2020)
Table Global Long-Acting Injectables Revenue Market Share by Regions in 2015
Table Global Long-Acting Injectables Revenue Market Share by Regions in 2019
Figure North America Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Europe Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure South America Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure North America Long-Acting Injectables Revenue ($) and Growth (2015-2020)
Table North America Long-Acting Injectables Sales by Countries (2015-2020)
Table North America Long-Acting Injectables Sales Market Share by Countries (2015-2020)
Figure North America Long-Acting Injectables Sales Market Share by Countries in 2015
Figure North America Long-Acting Injectables Sales Market Share by Countries in 2019
Table North America Long-Acting Injectables Revenue ($) by Countries (2015-2020)
Table North America Long-Acting Injectables Revenue Market Share by Countries (2015-2020)
Figure North America Long-Acting Injectables Revenue Market Share by Countries in 2015
Figure North America Long-Acting Injectables Revenue Market Share by Countries in 2019
Figure United States Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Canada Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Mexico Long-Acting Injectables Sales and Growth (2015-2020)
Figure Europe Long-Acting Injectables Revenue ($) Growth (2015-2020)
Table Europe Long-Acting Injectables Sales by Countries (2015-2020)
Table Europe Long-Acting Injectables Sales Market Share by Countries (2015-2020)
Figure Europe Long-Acting Injectables Sales Market Share by Countries in 2015
Figure Europe Long-Acting Injectables Sales Market Share by Countries in 2019
Table Europe Long-Acting Injectables Revenue ($) by Countries (2015-2020)
Table Europe Long-Acting Injectables Revenue Market Share by Countries (2015-2020)
Figure Europe Long-Acting Injectables Revenue Market Share by Countries in 2015
Figure Europe Long-Acting Injectables Revenue Market Share by Countries in 2019
Figure Germany Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure UK Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure France Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Italy Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Spain Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Russia Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Long-Acting Injectables Revenue ($) and Growth (2015-2020)
Table Asia-Pacific Long-Acting Injectables Sales by Countries (2015-2020)
Table Asia-Pacific Long-Acting Injectables Sales Market Share by Countries (2015-2020)
Figure Asia-Pacific Long-Acting Injectables Sales Market Share by Countries in 2015
Figure Asia-Pacific Long-Acting Injectables Sales Market Share by Countries in 2019
Table Asia-Pacific Long-Acting Injectables Revenue ($) by Countries (2015-2020)
Table Asia-Pacific Long-Acting Injectables Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Long-Acting Injectables Revenue Market Share by Countries in 2015
Figure Asia-Pacific Long-Acting Injectables Revenue Market Share by Countries in 2019
Figure China Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Japan Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure South Korea Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Australia Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure India Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Southeast Asia Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Long-Acting Injectables Revenue ($) and Growth (2015-2020)
Table Middle East and Africa Long-Acting Injectables Sales by Countries (2015-2020)
Table Middle East and Africa Long-Acting Injectables Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Long-Acting Injectables Revenue ($) by Countries (2015-2020)
Table Middle East and Africa Long-Acting Injectables Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Long-Acting Injectables Revenue Market Share by Countries in 2015
Figure Middle East and Africa Long-Acting Injectables Revenue Market Share by Countries in 2019
Figure Saudi Arabia Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure UAE Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Egypt Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Nigeria Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure South Africa Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure South America Long-Acting Injectables Revenue ($) and Growth (2015-2020)
Table South America Long-Acting Injectables Sales by Countries (2015-2020)
Table South America Long-Acting Injectables Sales Market Share by Countries (2015-2020)
Table South America Long-Acting Injectables Revenue ($) by Countries (2015-2020)
Table South America Long-Acting Injectables Revenue Market Share by Countries (2015-2020)
Figure South America Long-Acting Injectables Revenue Market Share by Countries in 2015
Figure South America Long-Acting Injectables Revenue Market Share by Countries in 2019
Figure Brazil Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Argentina Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Columbia Long-Acting Injectables Sales and Growth Rate (2015-2020)
Figure Chile Long-Acting Injectables Sales and Growth Rate (2015-2020)
Table Global Long-Acting Injectables Sales by Types (2015-2020)
Table Global Long-Acting Injectables Sales Share by Types (2015-2020)
Table Global Long-Acting Injectables Revenue ($) by Types (2015-2020)
Table Global Long-Acting Injectables Revenue Share by Types (2015-2020)
Figure Global Small and Middle Sized Molecule Sales and Growth Rate (2015-2020)
Figure Global Small and Middle Sized Molecule Price (2015-2020)
Figure Global Large Sized Molecule Sales and Growth Rate (2015-2020)
Figure Global Large Sized Molecule Price (2015-2020)
Table Global Long-Acting Injectables Sales by Applications (2015-2020)
Table Global Long-Acting Injectables Sales Share by Applications (2015-2020)
Figure Global Schizophrenia Sales and Growth Rate (2015-2020)
Figure Global Schizophrenia Revenue and Growth Rate (2015-2020)
Figure Global Other Psychotic Disorders Sales and Growth Rate (2015-2020)
Figure Global Other Psychotic Disorders Revenue and Growth Rate (2015-2020)
Figure Global Long-Acting Injectables Sales and Growth Rate (2020-2026)
Figure Global Long-Acting Injectables Revenue ($) and Growth Rate (2020-2026)
Table Global Long-Acting Injectables Sales Forecast by Regions (2020-2026)
Table Global Long-Acting Injectables Revenue Forecast by Regions (2020-2026)
Figure North America Long-Acting Injectables Sales Forecast (2020-2026)
Figure North America Long-Acting Injectables Revenue Forecast (2020-2026)
Figure Europe Long-Acting Injectables Sales Forecast (2020-2026)
Figure Europe Long-Acting Injectables Revenue Forecast (2020-2026)
Figure Asia-Pacific Long-Acting Injectables Sales Forecast (2020-2026)
Figure Asia-Pacific Long-Acting Injectables Revenue Forecast (2020-2026)
Figure Middle East and Africa Long-Acting Injectables Sales Forecast (2020-2026)
Figure Middle East and Africa Long-Acting Injectables Revenue Forecast (2020-2026)
Figure South America Long-Acting Injectables Sales Forecast (2020-2026)
Figure South America Long-Acting Injectables Revenue Forecast (2020-2026)
Table Global Long-Acting Injectables Sales Forecast by Types (2020-2026)
Table Global Long-Acting Injectables Sales Market Share Forecast by Types (2020-2026)
Table Global Long-Acting Injectables Revenue Forecast by Types (2020-2026)
Table Global Long-Acting Injectables Revenue Market Share Forecast by Types (2020-2026)
Table Global Long-Acting Injectables Sales Forecast by Applications (2020-2026)
Table Global Long-Acting Injectables Sales Market Share Forecast by Applications (2020-2026)
Table Global Long-Acting Injectables Revenue Forecast by Applications (2020-2026)
Table Global Long-Acting Injectables Revenue Market Share Forecast by Applications (2020-2026)

  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs